Position
Sovran Advisors, LLC in Thermo Fisher Scientific Inc.
Back to the book · All holders of TMO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$59.7K$624.65 → $479.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 410 | $256.1K | — | — | — | 0.0% |
| Q1 2026 | 452 | $216.5K | $479.01 | −$59.7K | $20.1K | 0.0% |